MergerLinks Header Logo

Request Deal Involvement

Altaris Capital Partners to acquire the Generic Rx unit of Perrigo for $1.5bn.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Centerview Partners

financial advisors

Centerview Partners

Wachtell Lipton Rosen & Katz

legal advisors

Wachtell Lipton Rosen & Katz

Gibson Dunn & Crutcher

legal advisors to financial advisors

Gibson Dunn & Crutcher

Fischer Behar Chen Well Orion & Co

legal advisors

Fischer Behar Chen Well Orion & Co

Schiff Hardin

legal advisors

Schiff Hardin

Goldman Sachs

financial advisors

Goldman Sachs

JP Morgan

financial advisors

JP Morgan

Cleary Gottlieb Steen & Hamilton

legal advisors

Cleary Gottlieb Steen & Hamilton

JP Morgan

debt providers

JP Morgan

Yigal Arnon & Co

legal advisors

Yigal Arnon & Co

Goldman Sachs

debt providers

Goldman Sachs

or

Principals

PERRIGO (GENERIC RX BUSINESS)

target

PERRIGO (GENERIC RX BUSINESS)

PERRIGO COMPANY PLC

vendor

PERRIGO COMPANY PLC

ALTARIS LLC

bidder

ALTARIS LLC

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite